The Advisory Committee on the Medical Uses of Isotopes (ACMUI) advises the U.S. Nuclear Regulatory Commission (NRC) on policy and technical issues that arise in the regulation of the medical uses of radioactive material in diagnosis and therapy. The ACMUI membership includes health care professionals from various disciplines, who comment on changes to NRC regulations and guidance; evaluate certain non-routine uses of radioactive material; provide technical assistance in licensing, inspection, and enforcement cases; and bring key issues to the attention of the Commission for appropriate action.
As an official advisory body to the NRC staff, the ACMUI's operational practices are governed by the provisions of the Federal Advisory Committee Act (FACA). Advisory committees are structured to provide a forum where experts representing many technical perspectives can provide independent advice that is factored into the NRC’s decision-making process.
See the following for more information:
Page Last Reviewed/Updated Thursday, February 04, 2021